x
Breaking News
0

Valeant Pharmaceuticals International Inc (VRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Valeant Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
14.39 +0.05    +0.35%
18/08 - Closed. Currency in USD ( Disclaimer )
After Hours
14.39
0.00
0.00%
18:40:01 - Real-time Data
Type: Equity
Market: United States
ISIN: CA91911K1021 
CUSIP: 91911K102
  • Volume: 10,472,002
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 14.17 - 14.54
START TRADING NOW
Valeant Pharmaceuticals 14.39 +0.05 +0.35%

VRX Overview

 
Information about the Valeant Pharmaceuticals International Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close14.34
Day's Range14.17 - 14.54
Revenue9.22B
Open14.36
52 wk Range8.31 - 32.74
EPS - 3.27
Volume10,472,002
Market Cap4.99B
Dividend (Yield)0 (N/A)
Average Volume (3m)18,459,606
P/E RatioN/A
Beta - 0.31
1-Year Change - 49.93%
Shares Outstanding347,330,223
Next Earnings DateNov 06, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Sell Strong Sell Sell Sell
Technical Indicators Strong Sell Strong Sell Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Engulfing Bearish 15 Current
Shooting Star 30 Current
Completed Patterns
Falling Three Methods 1W 2 Jul 30, 2017
Doji Star Bearish 15 2 Aug 18, 2017 15:15
Bullish Engulfing 1M 3 May 17

Valeant Pharmaceuticals International Inc News & Analysis

Valeant Pharmaceuticals International Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NYSE 14.39 0.00 0.00 10,472,002 +0.35% USD 18/08  
  Toronto 18.08 18.07 18.11 996,055 -0.55% CAD 18/08  
  Mexico 258.99 240.00 258.99 0 0.00% MXN 17/08  
  Switzerland 15.060 0.000 0.000 0 0.00% CHF 09/08  
  Stuttgart 12.196 0.000 0.000 3,040 -1.29% EUR 18/08  
  Munich 12.175 0.000 0.000 0 +0.95% EUR 18/08  
  Berlin 12.170 0.000 0.000 0 +0.91% EUR 18/08  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Canopy Growth 8.760 8.880 8.730 -0.090 -1.02% 501.78K 18/08  
  Amazon.com 958.47 965.43 954.65 -2.10 -0.22% 3.28M 18/08  
  Aphria 5.840 5.950 5.820 -0.040 -0.68% 422.36K 18/08  
  Apple 157.50 159.50 156.72 -0.36 -0.23% 27.43M 18/08  
  Aurora Cannabis 2.470 2.480 2.430 0.000 0.00% 495.84K 18/08  
  NVIDIA 161.50 164.36 159.64 +0.03 +0.02% 15.03M 18/08  
  Alibaba 167.50 169.50 164.10 +3.58 +2.18% 31.49M 18/08  
  Snap 14.01 14.25 13.26 +0.66 +4.94% 46.20M 18/08  
  Tesla 347.46 354.00 345.80 -4.46 -1.27% 5.41M 18/08  
  Facebook 167.41 168.67 166.21 +0.50 +0.30% 15.09M 18/08  

Valeant Pharmaceuticals International Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

21500

Equity Type

ORD

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets. In the Developed Markets segment, it focuses on the areas of dermatology, neurology, gastrointestinal disorders, and eye health therapeutic classes. In the Emerging Markets segment, it focuses on primarily on branded generics, OTC products and medical devices. Its pharmaceutical products include Xifaxan, Solodyn and Glumetza. Its OTC products include PreserVision, Biotrue and Boston. Its other generic products include Latanoprost and Metronidazole. Its ophthalmic surgical products include intraocular lenses, such as Akreos, enVista, Crystalens and Trulign.

Read More

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
100%
Bearish
0%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Valeant Pharmaceuticals International Inc
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest VRX Comments

Ose Collins
Ose Collins Jul 14, 2017 3:48 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My name is Santos and I have been looking for financial help for my marriage ceremony,  I got a master card from a friend on the internet and this card gives me 3000$ every day I am so happy to have this card because since last month i have been getting enough money from this card If you are poor or you need quick money you can also get this card just contact tarjetaservicio@gmail.com This card is a universal card  and anyone can get this card just contact tarjetaservicio@gmail.com I am so happy to post this here.
Reply
0 0
Srinath Gunaratne
Srinath Gunaratne Aug 14, 2016 4:30 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
Reply
0 0
Mohammed Ali
Mohammed Ali Jul 08, 2016 3:37 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
Reply
0 0
Jeremiah Cox
Jeremiah Cox Sep 26, 2016 17:33 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
Reply
0 0
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email